C(nn) and compassionate use: two approaches for early access. Proposals for a better management
Introduction: To ensure access to drugs prior to their marketing authorization and/or reimbursability, but outside of clinical trials, two modes of early drug access have been implemented: C(nn) and compassionate use (CU). The C(nn) class of drugs includes drugs in class C that have not yet been ne...
Saved in:
| Main Authors: | Alberto Bortolami, Irene Marzona, Paolo Stella, Valentina Acciai, Vito Ladisa, Massimo Medaglia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AboutScience Srl
2025-06-01
|
| Series: | Global & Regional Health Technology Assessment |
| Subjects: | |
| Online Access: | https://journals.aboutscience.eu/index.php/grhta/article/view/3464 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review
by: Clara Fatoye, et al.
Published: (2024-05-01) -
Market Access Challenges and Solutions in Cell and Gene Therapy in The Netherlands
by: Rimma Velikanova, et al.
Published: (2024-07-01) -
The patient ‘must find his own way’: public policies concerning access to medicines in Angola
by: Elisa Dulce João Fundanga Calipi, et al.
Published: (2025-12-01) -
Pharmaceutical market access in emerging markets: concepts, components, and future
by: Anuj Kumar, et al.
Published: (2014-12-01) -
Bridging multisensory and ud towards compassionate design in Malaysia interior design industry
by: Jia Yi Choy, et al.
Published: (2025-04-01)